About Accel Diagnostics
Accel Diagnostics is a company based in Pittsburgh (United States) founded in 2012.. Accel Diagnostics has raised $950 thousand across 4 funding rounds from investors including Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab. Accel Diagnostics offers products and services including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests. Accel Diagnostics operates in a competitive market with competitors including ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$950 K (USD)
in 4 rounds
-
Latest Funding Round
$200 K (USD), Seed
Apr 25, 2013
-
Investors
Innovation Works
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accel Diagnostics
Accel Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides RT-PCR and antigen tests for COVID-19 detection and travel needs.
Offers panels for detecting various substances in urine samples.
Includes annual check-ups for liver, kidney, and thyroid functions.
Detects common sexually transmitted infections for early treatment.
Covers blood counts, lipid panels, and hormone tests for overall health.
Funding Insights of Accel Diagnostics
Accel Diagnostics has successfully raised a total of $950K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $200,000
-
First Round
First Round
(10 Feb 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2013 | Amount | Seed - Accel Diagnostics | Valuation |
investors |
|
| Sep, 2012 | Amount | Angel Round - Accel Diagnostics | Valuation |
investors |
|
| Jun, 2012 | Amount | Seed - Accel Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Accel Diagnostics
Accel Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accelerator programs supporting startups in technology sectors, including software and robotics, in Pittsburgh.
|
Founded Year | Domain | Location | |
|
Software, hardware, and life sciences startups are funded and accelerated.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Accel Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Accel Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accel Diagnostics Comparisons
Competitors of Accel Diagnostics
Accel Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microfluidic technology and solutions are provided for life sciences industries.
|
|
| domain | founded_year | HQ Location |
Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI
|
|
| domain | founded_year | HQ Location |
Microgravity research solutions are provided for researchers and companies.
|
|
| domain | founded_year | HQ Location |
Microfluidic devices and lab-on-chip solutions are designed and manufactured.
|
|
| domain | founded_year | HQ Location |
Point-of-care instruments for diagnostics and research are developed.
|
|
| domain | founded_year | HQ Location |
Microfluidics and microtechnology solutions are developed for drug permeability testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Accel Diagnostics
When was Accel Diagnostics founded?
Accel Diagnostics was founded in 2012.
Where is Accel Diagnostics located?
Accel Diagnostics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Is Accel Diagnostics a funded company?
Accel Diagnostics is a funded company, having raised a total of $950K across 4 funding rounds to date. The company's 1st funding round was a Seed of $100K, raised on Feb 10, 2012.
What does Accel Diagnostics do?
Accel Diagnostics (AccelDx) is a medical technology company. Its product pScreen is a finger-prick blood test for the diagnosis, monitoring and management of a wide variety of diseases and medical conditions, including heart failure, cancer, womens health and infectious diseases. Users apply a small drop of body fluid (e.g., finger prick blood, urine) onto the pScreen. In less than 20 minutes, pScreen allows them to monitor and track the level of proteins (biomarkers) that map the health risk of the patient. It enables patients to monitor and effectively manage the progression of their chronic diseases. Users can scan the pScreen card with their smartphone to communicate the results to their healthcare provider.
Who are the top competitors of Accel Diagnostics?
Accel Diagnostics's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.
What products or services does Accel Diagnostics offer?
Accel Diagnostics offers COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests.
Who are Accel Diagnostics's investors?
Accel Diagnostics has 3 investors. Key investors include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University, and AlphaLab.